Works matching DE "ETRAVIRINE (Drug)"
Results: 99
Retrospective study of the prevalence of acquired drug resistance after failed antiretroviral therapy in Libya.
- Published in:
- Eastern Mediterranean Health Journal, 2024, v. 30, n. 7, p. 470, doi. 10.26719/2024.30.7.470
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 1, p. 25, doi. 10.2165/11534740-000000000-00000
- Publication type:
- Article
Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.
- Published in:
- Journal of Infection in Developing Countries, 2016, v. 10, n. 6, p. 605, doi. 10.3855/jidc.7512
- By:
- Publication type:
- Article
Raltegravir dosage adjustment in HIV-infected patients receiving etravirine.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 21, p. 2049, doi. 10.2146/ajhp110083
- By:
- Publication type:
- Article
OF SPECIAL INTEREST.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 21, p. 2003
- Publication type:
- Article
Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
- Published in:
- HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525
- By:
- Publication type:
- Article
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
- Published in:
- HIV Medicine, 2016, v. 17, n. 1, p. 62, doi. 10.1111/hiv.12274
- By:
- Publication type:
- Article
The Intelence aNd pRezista Once A Day Study ( INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 288, doi. 10.1111/hiv.12211
- By:
- Publication type:
- Article
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
- By:
- Publication type:
- Article
Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study.
- Published in:
- HIV Medicine, 2014, v. 15, n. 9, p. 513, doi. 10.1111/hiv.12141
- By:
- Publication type:
- Article
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 421, doi. 10.1111/hiv.12019
- By:
- Publication type:
- Article
Etravirine resistance mutations in HIV-infected pregnant women Etravirine resistance mutations in HIV-infected pregnant women.
- Published in:
- HIV Medicine, 2013, v. 14, n. 2, p. 125, doi. 10.1111/j.1468-1293.2012.01058.x
- By:
- Publication type:
- Article
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 427, doi. 10.1111/j.1468-1293.2012.00994.x
- By:
- Publication type:
- Article
Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients.
- Published in:
- HIV Medicine, 2011, v. 12, n. 7, p. 442, doi. 10.1111/j.1468-1293.2010.00907.x
- By:
- Publication type:
- Article
Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women.
- Published in:
- HIV Medicine, 2011, v. 12, n. 4, p. 257, doi. 10.1111/j.1468-1293.2010.00874.x
- By:
- Publication type:
- Article
Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2017, v. 7, p. 1, doi. 10.3389/fcimb.2017.00329
- By:
- Publication type:
- Article
Development of a practical synthesis of etravirine via a microwave-promoted amination.
- Published in:
- Chemistry Central Journal, 2018, v. 12, n. 1, p. 1, doi. 10.1186/s13065-018-0504-4
- By:
- Publication type:
- Article
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study
- Published in:
- Pharmacotherapy, 2019, v. 39, n. 4, p. 514, doi. 10.1002/phar.2242
- By:
- Publication type:
- Article
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2084, doi. 10.1093/jac/dkv049
- By:
- Publication type:
- Article
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2090, doi. 10.1093/jac/dkv048
- By:
- Publication type:
- Article
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2531, doi. 10.1093/jac/dku153
- By:
- Publication type:
- Article
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 4, p. 1090
- By:
- Publication type:
- Article
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
- By:
- Publication type:
- Article
Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 11, p. 2515, doi. 10.1093/jac/dkt251
- By:
- Publication type:
- Article
Prevalence and risk factors associated with resistance-associated mutations to etravirine in a cohort of perinatally HIV-infected children.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2344
- By:
- Publication type:
- Article
Etravirine in CSF is highly protein bound.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 5, p. 1161
- By:
- Publication type:
- Article
Etravirine concentrations in seminal plasma in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 184, doi. 10.1093/jac/dks360
- By:
- Publication type:
- Article
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 11, p. 2779
- By:
- Publication type:
- Article
Etravirine concentrations in CSF in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1446, doi. 10.1093/jac/dks048
- By:
- Publication type:
- Article
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 685
- By:
- Publication type:
- Article
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 681, doi. 10.1093/jac/dkr534
- By:
- Publication type:
- Article
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 7, p. 1573, doi. 10.1093/jac/dkr151
- By:
- Publication type:
- Article
Focus on 2010: A year of novel pharmacologic agents in review.
- Published in:
- Formulary, 2010, v. 45, n. 11, p. 350
- Publication type:
- Article
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00239
- By:
- Publication type:
- Article
Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China.
- Published in:
- Virology Journal, 2019, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12985-018-1112-6
- By:
- Publication type:
- Article
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa.
- Published in:
- AIDS Research & Therapy, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12981-018-0196-9
- By:
- Publication type:
- Article
Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 1, p. 105, doi. 10.1007/s10156-010-0082-4
- By:
- Publication type:
- Article
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2017, v. 6, n. 3, p. 294, doi. 10.1093/jpids/piw017
- By:
- Publication type:
- Article
Intracellular and plasma steady-state pharmacokinetics of raltegravir, darunavir, etravirine and ritonavir in heavily pre-treated HIV-infected patients.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 5, p. 475, doi. 10.1111/j.1365-2125.2010.03634.x
- By:
- Publication type:
- Article
Etravirine: A Guide to Its Use in Treatment-Experienced Pediatric Patients with HIV-1 Infection in the US.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 5, p. 345, doi. 10.2165/11209720-000000000-00000
- By:
- Publication type:
- Article
Role of Rilpivirine and Etravirine in Efavirenz and Nevirapine-Based Regimens Failure in a Resource-Limited Country: A Cross- Sectional Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0154221
- By:
- Publication type:
- Article
Product Update.
- Published in:
- Canadian Pharmacists Journal, 2013, v. 146, n. 1, p. 18, doi. 10.1177/1715163512473724
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 11, p. 1395, doi. 10.1002/jcph.746
- By:
- Publication type:
- Article
The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 4, p. 422, doi. 10.1002/jcph.214
- By:
- Publication type:
- Article
Steady-State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV-Negative Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 2, p. 202, doi. 10.1177/0091270012445205
- By:
- Publication type:
- Article
Pharmacokinetics and Short-Term Safety of Etravirine in Combination With Fluconazole or Voriconazole in HIV-Negative Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 1, p. 41, doi. 10.1177/0091270011433329
- By:
- Publication type:
- Article
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 3, p. 440, doi. 10.1177/0091270010395939
- By:
- Publication type:
- Article
Clinical Pharmacology Profile of Raltegravir, an HIV-1 Integrase Strand Transfer Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 10, p. 1376, doi. 10.1177/0091270010387428
- By:
- Publication type:
- Article
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.
- Published in:
- Infectious Diseases, 2016, v. 48, n. 5, p. 392, doi. 10.3109/23744235.2015.1133927
- By:
- Publication type:
- Article